Gastric Acid Secretion
Showing 1 - 25 of >10,000
Pulmonary Disease, Chronic Obstructive Trial in Overland Park (Danirixin, Omeprazole)
Completed
- Pulmonary Disease, Chronic Obstructive
-
Overland Park, KansasGSK Investigational Site
Apr 27, 2021
Severe Obesity Trial in Hvidovre (Chenodeoxycholic Acid, Colesevelam)
Completed
- Severe Obesity
- Chenodeoxycholic Acid
- Colesevelam
-
Hvidovre, DK, DenmarkHvidovre University Hospital
Nov 25, 2020
Severe Obesity Trial in Hvidovre (Colesevelam, Chenodeoxycholic Acid, Water)
Completed
- Severe Obesity
- Colesevelam
- +2 more
-
Hvidovre, DenmarkHvidovre University Hospital
Nov 25, 2020
Serum Bile Acid Profile in the Diagnosis of Gastric Cancer
Recruiting
- Gastric Cancer
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Sep 10, 2023
A New Method for Determining Gastric Acid Output UsingWireless
Completed
- Gastric Acid Secretory Disorders
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Hemorrhage, Bleeding Trial (Tranexamic Acid Injection [Cyklokapron], Sodium chloride 0.9%)
Not yet recruiting
- Hemorrhage
- Bleeding
- Tranexamic Acid Injection [Cyklokapron]
- Sodium chloride 0.9%
- (no location specified)
Jul 15, 2022
Type 2 Diabetes, Morbid Obesity Trial in Tønsberg (Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy,
Active, not recruiting
- Type 2 Diabetes
- Morbid Obesity
- Bariatric surgery, either gastric bypass surgery or sleeve gastrectomy
- +2 more
-
Tønsberg, Vestfold, NorwayThe Morbid Obesity Center, Vestfold Hospital Trust
Jun 1, 2022
Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)
Not yet recruiting
- Gastric Cancer
- +2 more
- TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- (no location specified)
Oct 16, 2023
Hypochlorhydria Trial in Indianapolis (Omeprazole 20mg, Vitamin C)
Recruiting
- Hypochlorhydria
- Omeprazole 20mg
- Vitamin C
-
Indianapolis, IndianaIndiana University School of Medicine
Mar 28, 2022
Oesophageal Reflux, Gastric Reflux, Hyperactivity; Stomach Trial in Barcelona (Antacid, Control)
Active, not recruiting
- Oesophageal Reflux
- +2 more
- Antacid
- Control
-
Barcelona, SpainOriol Armengol
Aug 1, 2022
Tuberculosis Trial (Quantiferon Gold, HIV serology, Respiratory secretion culture (sputum or gastric aspirate_)
Not yet recruiting
- Tuberculosis
- Quantiferon Gold
- +5 more
- (no location specified)
Oct 27, 2023
Gastric Polyp, Gastric Tumor, Duodenal Tumors Trial in Be'er Ya'aqov (Tranexamic acid, Epinephrine injection)
Not yet recruiting
- Gastric Polyp
- +3 more
- Tranexamic acid
- Epinephrine injection
-
Be'er Ya'aqov, IsraelShamir Medical Center
Jan 8, 2023
Gastric Residual Volume Trial in Cairo (Domperidone, Folic acid)
Active, not recruiting
- Gastric Residual Volume
- Domperidone
- Folic acid
-
Cairo, EgyptAin Shams University hospitals
Dec 20, 2022
Coronary Artery Disease Trial (Lansoprazole 15 mg)
Not yet recruiting
- Coronary Artery Disease
- Lansoprazole 15 mg
- (no location specified)
Apr 6, 2023
Obesity Trial in Rochester (Roux-En-Y Gastric Bypass, Low-calorie Diet)
Completed
- Obesity
- Roux-En-Y Gastric Bypass
- Low-calorie Diet
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 21, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Gastric Cancer Trial in Seoul (Patients who continued UDCA 300mg medication, Patients who discontinued UDCA 300mg prescription)
Recruiting
- Gastric Cancer
- Patients who continued UDCA 300mg medication
- Patients who discontinued UDCA 300mg prescription
-
Seoul, Korea, Republic ofDoJoong Park
Jun 6, 2022
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage II Gastric Cancer AJCC v8, Clinical Stage II Gastroesophageal Junction
Not yet recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +9 more
- Atezolizumab
- +12 more
- (no location specified)
Apr 26, 2023
HIV Trial in Baltimore (Ranitidine HCl, Foscarnet sodium)
Completed
- HIV Infections
- Ranitidine hydrochloride
- Foscarnet sodium
-
Baltimore, MarylandJohns Hopkins Adult AIDS CRS
Oct 28, 2021
Coronary Artery Disease, Gastroesophageal Reflux Disease Trial in Beijing (Indobufen and aspirin mimetic, Aspirin and indobufen
Unknown status
- Coronary Artery Disease
- Gastroesophageal Reflux Disease
- Indobufen and aspirin mimetic
- Aspirin and indobufen mimetic
-
Beijing, ChinaBeijing Anzhen Hospital, Capital Medical University
Oct 14, 2019
Healthy Volunteers Trial in Tempe (Maribavir Commercial Tablet Formulation, Maribavir Pediatric Powder-for-oral Suspension
Not yet recruiting
- Healthy Volunteers
- Maribavir Commercial Tablet Formulation
- +2 more
-
Tempe, ArizonaCelerion
Jun 16, 2023
Bile Reflux, Gastric Cancer, Precancerous Lesion Trial in Xi'an
Enrolling by invitation
- Bile Reflux
- +2 more
-
Xi'an, Shaanxi, ChinaXijing Hosipital of Digestive Disease
Apr 6, 2021
Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,
Active, not recruiting
- Gastric Cardia Adenocarcinoma
- +7 more
- Carboplatin
- +10 more
-
Phoenix, Arizona
- +1 more
May 12, 2022
Gastric Cancer Trial in Australia, New Zealand (drug, radiation, procedure)
Active, not recruiting
- Gastric Cancer
- Epirubicin + cisplatin + 5-fluorouracil OR epirubicin + cisplatin + capecitabine OR epirubicin + oxaliplatin + capecitabine OR 5-Fluorouracil + leucovorin + oxaliplatin + docetaxel
- +2 more
-
Newcastle, New South Wales, Australia
- +22 more
Mar 21, 2022